ArticleClinical and translational medicine2022

Inhibition of proteasomal deubiquitinases USP14 and UCHL5 overcomes tyrosine kinase inhibitor resistance in chronic myeloid leukaemia.

Liling Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.